![]() |
Name |
(2S)-2-hydroxy-2-[[(2S)-4-(1-hydroxyocta-2,4-dienylidene)-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl]-3-methylbutanoic acid
|
Molecular Formula | C19H27NO6 | |
IUPAC Name* |
(2S)-2-hydroxy-2-[[(2S)-4-(1-hydroxyocta-2,4-dienylidene)-1-methyl-3,5-dioxopyrrolidin-2-yl]methyl]-3-methylbutanoic acid
|
|
SMILES |
CCCC=CC=CC(=C1C(=O)[C@@H](N(C1=O)C)C[C@](C(C)C)(C(=O)O)O)O
|
|
InChI |
InChI=1S/C19H27NO6/c1-5-6-7-8-9-10-14(21)15-16(22)13(20(4)17(15)23)11-19(26,12(2)3)18(24)25/h7-10,12-13,21,26H,5-6,11H2,1-4H3,(H,24,25)/t13-,19-/m0/s1
|
|
InChIKey |
FQSWTHMMNDRFAI-DJJJIMSYSA-N
|
|
Synonyms |
Harzianic acid
|
|
CAS | NA | |
PubChem CID | 139585999 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 365.4 | ALogp: | 3.1 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 26 | QED Weighted: | 0.264 |
Caco-2 Permeability: | -5.129 | MDCK Permeability: | 0.00002000 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.077 |
Human Intestinal Absorption (HIA): | 0.041 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.068 | Plasma Protein Binding (PPB): | 92.66% |
Volume Distribution (VD): | 1.149 | Fu: | 3.11% |
CYP1A2-inhibitor: | 0.055 | CYP1A2-substrate: | 0.103 |
CYP2C19-inhibitor: | 0.021 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.072 | CYP2C9-substrate: | 0.568 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.189 |
CYP3A4-inhibitor: | 0.025 | CYP3A4-substrate: | 0.198 |
Clearance (CL): | 1.051 | Half-life (T1/2): | 0.419 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.442 |
Drug-inuced Liver Injury (DILI): | 0.206 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.134 | Maximum Recommended Daily Dose: | 0.914 |
Skin Sensitization: | 0.642 | Carcinogencity: | 0.813 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.045 |
Respiratory Toxicity: | 0.47 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002820 | ![]() |
0.718 | D0N3NO | ![]() |
0.235 | ||
ENC005202 | ![]() |
0.289 | D06FEA | ![]() |
0.212 | ||
ENC002818 | ![]() |
0.284 | D0F0YZ | ![]() |
0.196 | ||
ENC005385 | ![]() |
0.280 | D0R6BR | ![]() |
0.196 | ||
ENC002728 | ![]() |
0.267 | D06FVX | ![]() |
0.195 | ||
ENC003891 | ![]() |
0.266 | D0S8TD | ![]() |
0.192 | ||
ENC005838 | ![]() |
0.265 | D00SJE | ![]() |
0.189 | ||
ENC003579 | ![]() |
0.264 | D0HD9K | ![]() |
0.188 | ||
ENC002144 | ![]() |
0.260 | D0W5BS | ![]() |
0.186 | ||
ENC004028 | ![]() |
0.259 | D05PLH | ![]() |
0.186 |